Clinical trial
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients…
NCT01809769 · Shanghai AbelZeta Ltd., Industry · Completed
Key facts
| NCT number | NCT01809769 |
|---|---|
| Title | Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis |
| Official title | Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis by Intra-articular Injection: A PhaseⅠ/Ⅱa, Randomized and Double-blinded Clinical Trial |
| Lead sponsor | Shanghai AbelZeta Ltd., Industry |
| Collaborators | RenJi Hospital |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Knee Osteoarthritis |
| Intervention type | Biological |
| Interventions | Mesenchymal stem cells low-dose group, Mesenchymal stem cells mid-dose group, Mesenchymal stem cells high-dose group |
| Enrollment | 18 |
| Start date | Mar 1, 2013 |
| Primary completion | Mar 1, 2015 |
| Completion | Jul 1, 2015 |
| First posted | Mar 13, 2013 |
| Last update posted | Apr 4, 2016 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: